Evolution of the Average Target: Danaher Corporation

Evolution of the Target Price: Danaher Corporation

Changes in Analyst Recommendations: Danaher Corporation

517c0c9.xv-E6s27kuf185UjEBwJjNOR9UPEV6oz5gJSF1sg13o.orfyiIPu-K7My8BkU2VjyZrjsxO1OtJkkW8cRGlM4ACRoLfbnI7f1KG8oQ~1c63095d0f3d11a33a58d3b74477acaa
07-22 Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says MT
07-22 Deutsche Bank Adjusts Danaher Price Target to $240 From $250, Maintains Buy Rating MT
07-22 Morgan Stanley Adjusts Price Target on Danaher to $220 From $255, Maintains Overweight Rating MT
07-22 Wells Fargo Adjusts Price Target on Danaher to $195 From $212, Maintains Equalweight Rating MT
07-22 Stifel Adjusts Price Target on Danaher to $220 From $260, Maintains Buy Rating MT
07-22 Jefferies Adjusts Price Target on Danaher to $210 From $245, Maintains Buy Rating MT
07-22 Guggenheim Adjusts Price Target on Danaher to $200 From $235, Maintains Buy Rating MT
07-22 TD Cowen Adjusts Price Target on Danaher to $236 From $240, Maintains Buy Rating MT
07-22 Goldman Sachs Adjusts Price Target on Danaher to $210 From $230, Maintains Buy Rating MT
07-22 Leerink Partners Adjusts Price Target on Danaher to $240 From $270, Maintains Outperform Rating MT
07-21 RBC Raises Danaher Price Target to $215 From $200 MT
07-21 Evercore ISI Adjusts Price Target on Danaher to $205 From $230 MT
07-13 Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating MT
07-06 Evercore ISI Adjusts Price Target on Danaher to $230 From $232 MT
06-03 HSBC Adjusts Price Target on Danaher to $230 From $270, Maintains Buy Rating MT
05-15 Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says MT
05-15 Danaher Set for Growth Reacceleration Amid Strong Bioprocessing Trends, RBC Says MT
04-24 Argus Adjusts Price Target on Danaher to $230 From $265, Maintains Buy Rating MT
04-22 Morgan Stanley Cuts Price Target on Danaher to $255 From $270 MT
04-22 UBS Cuts Price Target on Danaher to $250 From $270, Maintains Buy Rating MT
04-22 Jefferies Adjusts Price Target on Danaher to $245 From $240, Maintains Buy Rating MT
04-22 Guggenheim Adjusts Price Target on Danaher to $235 From $275, Maintains Buy Rating MT
04-22 TD Cowen Adjusts Price Target on Danaher to $240 From $245, Maintains Buy Rating MT
04-22 Baird Adjusts Price Target on Danaher to $245 From $249, Maintains Outperform Rating MT
04-22 Wells Fargo Adjusts Price Target on Danaher to $212 From $240, Maintains Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.77%
+12.95%
+42.22%
+67.7%
+17.09%
+32.28%
+19.91%
+12.4%
-11.98%
+26.63%
Average +25.00%
Weighted average by Cap. +27.07%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
179.14USD
Average target price
228.61USD
Spread / Average Target
+27.61%
High Price Target
310.00USD
Spread / Highest target
+73.05%
Low Price Target
195.00USD
Spread / Lowest Target
+8.85%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Evercore ISI
Baird
HSBC
Argus
Morgan Stanley
UBS
Guggenheim
JPMorgan Chase
Wells Fargo Securities
TD Cowen
Jefferies & Co.
Rothschild & Co Redburn
Barclays
Goldman Sachs
Wolfe Research
Deutsche Bank Securities
Leerink Partners
BofA Securities
Scotiabank
Redburn Atlantic
Stifel Nicolaus
Raymond James
Citigroup
KeyBanc Capital Markets
Stephens Inc.
Morningstar
SVB Securities LLC
Nephron Research
Credit Suisse
Cowen
Benchmark Company
Bernstein
B. Riley
Benchmark Capital
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
179.14USD
Average target price
228.61USD
Spread / Average Target
+27.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DHR Stock
  4. Consensus Danaher Corporation